Being “chronic” can be a good thing.
Launching Tasigna into the first-line indication means redefining the entire meaning of CML treatment. So we started by redefining the word “chronic.” It may sound bad, especially to patients who have been diagnosed with Chronic Myeloid Leukemia, but staying chronic is what helps them stay alive.
